MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Intuitive Surgical Inc

Slēgts

SektorsVeselības aprūpe

508.22 4.01

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

487.19

Max

511.37

Galvenie mērījumi

By Trading Economics

Ienākumi

123M

688M

Pārdošana

374M

2.4B

P/E

Sektora vidējais

72.947

57.333

EPS

2.21

Peļņas marža

28.506

Darbinieki

15,638

EBITDA

116M

810M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+21.36% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-39B

168B

Iepriekšējā atvēršanas cena

504.21

Iepriekšējā slēgšanas cena

508.22

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

Intuitive Surgical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. apr. 20:55 UTC

Peļņas

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

2025. g. 23. janv. 21:41 UTC

Peļņas

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

2025. g. 21. janv. 18:37 UTC

Iegādes, apvienošanās, pārņemšana

Intuitive to Establish Direct Presence in Europe With Acquisition

2024. g. 18. okt. 15:22 UTC

Peļņas
Galvenie tirgus virzītāji

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

2024. g. 17. okt. 21:33 UTC

Peļņas
Galvenie tirgus virzītāji

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

2024. g. 17. okt. 20:56 UTC

Peļņas

Intuitive Surgical Posts 3Q Revenue Growth

2025. g. 22. apr. 20:13 UTC

Peļņas

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

2025. g. 22. apr. 20:05 UTC

Peļņas

Intuitive Surgical 1Q EPS $1.92 >ISRG

2025. g. 22. apr. 20:05 UTC

Peļņas

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

2025. g. 22. apr. 20:05 UTC

Peļņas

Intuitive Surgical 1Q Net $698.4M >ISRG

2025. g. 22. apr. 20:05 UTC

Peļņas

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

2025. g. 22. apr. 20:05 UTC

Peļņas

Intuitive Surgical 1Q Rev $2.25B >ISRG

2025. g. 24. janv. 21:17 UTC

Peļņas

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

2025. g. 24. janv. 18:18 UTC

Peļņas

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

2025. g. 24. janv. 13:11 UTC

Top Ziņas

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

2025. g. 24. janv. 09:51 UTC

Karstas akcijas

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

2025. g. 23. janv. 21:10 UTC

Peļņas

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

2025. g. 23. janv. 21:09 UTC

Peļņas

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

2025. g. 23. janv. 21:09 UTC

Peļņas

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

2025. g. 23. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

2025. g. 23. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

2025. g. 23. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Rev $2.41B >ISRG

2025. g. 23. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Net $685.7M >ISRG

2025. g. 23. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q EPS $1.88 >ISRG

2025. g. 15. janv. 17:27 UTC

Peļņas

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

2025. g. 6. janv. 12:00 UTC

Top Ziņas

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

2024. g. 18. okt. 15:59 UTC

Peļņas

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024. g. 18. okt. 15:38 UTC

Peļņas

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

2024. g. 18. okt. 13:28 UTC

Peļņas

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024. g. 17. okt. 21:18 UTC

Peļņas
Galvenie tirgus virzītāji

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Salīdzinājums

Cenas izmaiņa

Intuitive Surgical Inc Prognoze

Cenas mērķis

By TipRanks

21.36% augšup

Prognoze 12 mēnešiem

Vidējais 592.13 USD  21.36%

Augstākais 675 USD

Zemākais 470 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Intuitive Surgical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

15

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

483.69 / 489.52Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Weak Bullish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.